• iconNews
  • videos
  • entertainment
  • Home
  • News
    • UK News
    • US News
    • Australia
    • Ireland
    • World News
    • Weird News
    • Viral News
    • Sport
    • Technology
    • Science
    • True Crime
    • Travel
  • Entertainment
    • Celebrity
    • TV & Film
    • Netflix
    • Music
    • Gaming
    • TikTok
  • LAD Originals
    • Say Maaate to a Mate
    • Daily Ladness
    • Lad Files
    • UOKM8?
    • FreeToBe
    • Extinct
    • Citizen Reef
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • UNILAD
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
Snapchat
TikTok
YouTube

LAD Entertainment

YouTube

LAD Stories

Submit Your Content
Cancer breakthrough as doctors celebrate new 'wonder drug'

Home> News> Health

Published 19:48 15 Feb 2024 GMT

Cancer breakthrough as doctors celebrate new 'wonder drug'

Scientists have developed a drug that combats against a hard-to-treat cancer.

Anish Vij

Anish Vij

One thing we can all agree on is that cancer is f**king horrible and the news of a breakthrough 'wonder drug' is always welcome.

Researchers have recently announced the 'truly wonderful development' of a new drug that is able to combat against a hard-to-treat cancer.

Advert

The new drug - developed by a team of scientists at Queen Mary University of London - helps treats mesothelioma, which is a type of cancer that develops in the lining that covers the outer surface of some of the body's organs.

With there being around 2,700 new cases of mesothelioma each year in the UK, just two percent of those people are expected to survive for 10 years beyond their diagnosis.

Scientists have developed a drug that combats against a hard-to-treat cancer.
Getty Stock Images

However, scientists have now claimed that the new treatment has 'quadrupled' three-year survival rates and increased average survival by 1.6 months.

249 patients who took part in the study - led by Professor Peter Szlosarek at London's Queen Mary university - all received chemotherapy every three weeks for up to six cycles.

Advert

Half were also provided with injections of new drug, called ADI-PEG20 (pegargiminase) while the other half received a placebo – also known as a dummy drug – for two years. Bare in mind that the average age of the patients were 70.

The ATOMIC-meso trial, which was sponsored by Polaris Pharmaceuticals, was conducted at 43 centres across five countries between 2017 and 2021.

“In this pivotal, randomised, placebo-controlled, phase 3 trial in 249 patients with pleural mesothelioma, pegargiminase-chemotherapy increased significantly the median overall survival by 1.6 months and quadrupled the survival at 36 months compared to placebo-chemotherapy,” the authors wrote.

“Pegargiminase-based chemotherapy was well tolerated with no new safety signals.”

Researchers have recently announced the 'truly wonderful development' of a new drug that is able to combat against a hard-to-treat cancer.
Getty Stock Images

Advert

Professor Szlosarek said: “It’s truly wonderful to see the research into the arginine starvation of cancer cells come to fruition.

“This discovery is something I have been driving from its earliest stages in the lab, with a new treatment, ADI-PEG20, now improving patient lives affected by mesothelioma.”

Dr Tayyaba Jiwani, science engagement manager at Cancer Research UK, which funded the early stages of the research, said: “This study shows the power of discovery research which allows us to dig deep into the biology of mesothelioma to uncover vulnerabilities that we can now target with ADI-PEG20.”

Liz Darlison, chief executive of the charity Mesothelioma UK, added: “The UK mesothelioma community, including doctors, nurses, patients and families living with mesothelioma, are extremely proud of ATOMiC.

“It offers another much needed treatment option and, above all, hope to those living with mesothelioma.

Advert

“We look forward to seeing this treatment become available as a standard option to all patients in the future.

“Well done to all concerned and thank you to everyone who took part.”

Featured Image Credit: Getty Stock Photos

Topics: Cancer, Health, Science

Anish Vij
Anish Vij

Anish is a Journalist at LADbible Group and is a GG2 Young Journalist of the Year 2025. He has a Master's degree in Multimedia Journalism and a Bachelor's degree in International Business Management. Apart from that, his life revolves around the ‘Four F’s’ - family, friends, football and food. Email: [email protected]

X

@Anish_Vij

Advert

Advert

Advert

Choose your content:

11 mins ago
an hour ago
2 hours ago
3 hours ago
  • 11 mins ago

    Man who won £5.4 million on lottery ended up homeless after one mistake 'destroyed his life'

    He claimed he never saw any of the winnings...

    News
  • an hour ago

    Why tug boats spray water into the air when towing ships as legendary wreckage is found by fisherman

    The spray is quite a sight to see, but why do tug boats do it?

    News
  • 2 hours ago

    Russian propagandist makes fresh nuclear bomb threat to UK wanting to teach 'scoundrel' Brits a lesson

    Nuclear threats appear to be a hot topic on Russian TV

    News
  • 3 hours ago

    Jay Slater's mum breaks down in tears in court after being asked about friends that 'can't be found'

    An inquest is underway into Jay Slater's tragic death last year, although key witnesses are missing from court

    News
  • Doctors share alarming information as 14 types of cancer rise in young people
  • Scientists pinpoint potential cause of colon cancer in young people in huge breakthrough
  • Doctors issue warning of three new factors driving certain cancer type as cases skyrocket in young people
  • Bowel cancer trial sees all patients disease-free in huge breakthrough